Artal Group S.A.
- SEC CIK
- 0001053906
- 最新申報
- 2026/8/13
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/11/12 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 140
- 較 2021 年第 2 季 +2
- 總值
- $40.7 億
- 較 2021 年第 2 季 −$3.28 億 (−7.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 71,178,364 | $3.42 億 | 8.4% | 00.0% | 不變 | 歷史 |
| WWWW International, Inc. | COM | 14,818,300 | $2.70 億 | 6.7% | 00.0% | 不變 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 650,000 | $2.36 億 | 5.8% | −200,000−23.5% | 減碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 1,200,000 | $2.12 億 | 5.2% | +350,000+41.2% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 577,308 | $1.74 億 | 4.3% | +77,308+15.5% | 加碼 | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 1,000,000 | $1.72 億 | 4.2% | −400,000−28.6% | 減碼 | 歷史 |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $1.64 億 | 4.0% | −838,366−15.0% | 減碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 700,000 | $1.32 億 | 3.3% | −50,000−6.7% | 減碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 1,585,049 | $8,978 萬 | 2.2% | −234,137−12.9% | 減碼 | 歷史 |
| IGMSIGM Biosciences, Inc. | COM | 1,350,000 | $8,878 萬 | 2.2% | +250,000+22.7% | 加碼 | 歷史 |
| FATEFate Therapeutics Inc | COM | 1,450,000 | $8,594 萬 | 2.1% | +100,000+7.4% | 加碼 | 歷史 |
| RUBYRubius Therapeutics, Inc. | COM | 4,155,625 | $7,430 萬 | 1.8% | −478,166−10.3% | 減碼 | 歷史 |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $7,055 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| ERASErasca, Inc. | COM | 3,172,221 | $6,732 萬 | 1.7% | +3,172,221 | 新進 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 1,950,000 | $6,439 萬 | 1.6% | −50,000−2.5% | 減碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 6,696,955 | $6,396 萬 | 1.6% | +2,946,955+78.6% | 加碼 | 歷史 |
| SGENSeagen Inc. | COM | 375,000 | $6,368 萬 | 1.6% | +375,000 | 新進 | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 825,000 | $5,980 萬 | 1.5% | +75,000+10.0% | 加碼 | 歷史 |
| KLRSKalaris Therapeutics, Inc. | COM | 2,323,371 | $5,822 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 1,800,000 | $5,310 萬 | 1.3% | −200,000−10.0% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 1,300,000 | $4,646 萬 | 1.1% | +800,000+160.0% | 加碼 | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 1,000,000 | $4,431 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,273,530 | $4,286 萬 | 1.1% | +2,273,530 | 新進 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 700,000 | $3,828 萬 | 0.9% | −97,445−12.2% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 600,000 | $3,806 萬 | 0.9% | +100,000+20.0% | 加碼 | 歷史 |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $3,693 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 275,000 | $3,689 萬 | 0.9% | +25,000+10.0% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 5,250,000 | $3,224 萬 | 0.8% | +500,000+10.5% | 加碼 | – |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $2,965 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| AGENAgenus Inc | COM NEW | 5,500,000 | $2,888 萬 | 0.7% | −500,000−8.3% | 減碼 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $2,799 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| KRONKronos Bio, Inc. | COM | 1,317,954 | $2,762 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,500,000 | $2,685 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 994,047 | $2,684 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| REPLReplimune Group, Inc. | COM | 900,000 | $2,668 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 800,000 | $2,662 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 1,500,000 | $2,658 萬 | 0.7% | +1,500,000 | 新進 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 500,000 | $2,611 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| DNLIDenali Therapeutics Inc. | COM | 500,000 | $2,523 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $2,397 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 400,000 | $2,350 萬 | 0.6% | +150,000+60.0% | 加碼 | 歷史 |
| TPTXTurning Point Therapeutics, Inc. | COM | 350,000 | $2,325 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,000,000 | $2,319 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $2,316 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $2,268 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $2,219 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $2,213 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,050,000 | $1,967 萬 | 0.5% | +450,000+75.0% | 加碼 | 歷史 |
| IMAImageneBio, Inc. | COM | 1,549,513 | $1,956 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $1,938 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 400,000 | $1,880 萬 | 0.5% | −100,000−20.0% | 減碼 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 600,000 | $1,872 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| NEXINexImmune, Inc. | COM | 1,200,000 | $1,817 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| NGNovagold Resources Inc | COM NEW | 2,600,000 | $1,789 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $1,757 萬 | 0.4% | 00.0% | 不變 | – |
| RNACCartesian Therapeutics, Inc. | COM | 4,000,000 | $1,664 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM | 4,000,000 | $1,604 萬 | 0.4% | +1,000,000+33.3% | 加碼 | 歷史 |
| BABAAlibaba Group Holding Ltd | ADR | 100,000 | $1,481 萬 | 0.4% | +100,000 | 新進 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 550,000 | $1,443 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ADAGAdagene Inc. | ADS | 1,000,000 | $1,437 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| APTXAptinyx Inc. | COM | 6,116,493 | $1,431 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| DRNADicerna Pharmaceuticals Inc | COM | 700,000 | $1,411 萬 | 0.3% | −100,000−12.5% | 減碼 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $1,393 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ZYMEZymeworks Inc. | COM | 450,000 | $1,307 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 400,000 | $1,261 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 250,000 | $1,172 萬 | 0.3% | −25,000−9.1% | 減碼 | 歷史 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 850,000 | $1,148 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $1,147 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $1,142 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 1,000,000 | $1,138 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $1,136 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 1,200,000 | $1,132 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $1,036 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 100,000 | $1,028 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CRISCuris Inc | COM NEW | 1,300,000 | $1,018 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 405,347 | $967.6 萬 | 0.2% | +405,347 | 新進 | 歷史 |
| SPROSpero Therapeutics, Inc. | COM | 500,000 | $920.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SANASana Biotechnology, Inc. | COM | 400,000 | $900.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM | 2,000,000 | $894.0 萬 | 0.2% | +300,000+17.6% | 加碼 | 歷史 |
| VORVor Biopharma Inc. | COM | 550,000 | $862.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| KRSAKorsana Biosciences, Inc. | COM | 2,779,122 | $853.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $852.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $840.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 400,000 | $836.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM | 1,045,000 | $830.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TILInstil Bio, Inc. | COM | 450,000 | $804.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IQiQIYI, Inc. | SPONSORED ADS | 1,000,000 | $803.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $790.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $741.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $730.1 萬 | 0.2% | 00.0% | 不變 | – |
| OLMAOlema Pharmaceuticals, Inc. | COM | 260,500 | $717.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 3,000,000 | $717.0 萬 | 0.2% | +750,000+33.3% | 加碼 | 歷史 |
| EVLOEvelo Biosciences, Inc. | COM | 1,000,000 | $704.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 1,000,000 | $671.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| APLTApplied Therapeutics, Inc. | COM | 400,000 | $664.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $651.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TCRRTCR2 Therapeutics Inc. | COM | 750,000 | $638.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $636.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 593,030 | $632.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 700,000 | $619.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
選擇權（6 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 2 季之後清倉（15 檔）
2021 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 2 季股數 | 2021 年第 2 季市值 | 2021 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 400,000 | $3,883 萬 | 0.9% | 歷史 |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 2,500,000 | $2,425 萬 | 0.6% | – |
| CARAvis Budget Group, Inc. | COM | 300,000 | $2,337 萬 | 0.5% | 歷史 |
| DLOdLocal Ltd | CLASS A COM | 295,000 | $1,550 萬 | 0.4% | 歷史 |
| LFSTLifeStance Health Group, Inc. | COM | 500,000 | $1,393 萬 | 0.3% | 歷史 |
| Translate Bio, Inc.89374L104 | COM | 500,000 | $1,377 萬 | 0.3% | – |
| AGLagilon health, inc. | COM | 300,000 | $1,217 萬 | 0.3% | 歷史 |
| NEUENeueHealth, Inc. | COM | 305,555 | $524.3 萬 | 0.1% | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 431,894 | $489.3 萬 | 0.1% | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 200,000 | $477.0 萬 | 0.1% | 歷史 |
| Paramount Global92556H206 | CL B | 75,000 | $339.0 萬 | 0.1% | – |
| MOLNMolecular Partners AG | ADS | 100,000 | $204.9 萬 | <0.1% | 歷史 |
| Chiasma, Inc16706W102 | COM | 380,000 | $179.7 萬 | <0.1% | – |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 79,600 | $114.5 萬 | <0.1% | – |
| LULufax Holding Ltd | ADS REP SHS CL A | 50,000 | $56.5 萬 | <0.1% | 歷史 |